PY

Punita Yadav

Active Director Director DIN 10084955
DIN 10084955 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Punita Yadav

Data last updated:

Punita Yadav is a Director at Payama Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Payama Pharmaceuticals Private Limited reported revenue of ₹2.8 Lakh (FY 2025).

DIN 10084955
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2023
Oldest Company Age 3 yrs
Largest company Payama Pharmaceuticals Private Limited · ₹2.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Mar 20232023₹2.8 Lakh (FY 2025)Active

Board colleagues of Punita Yadav

NameDINCompanyDesignation
Raj Kumar Yadav10084954Payama Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Payama Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Punita Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Punita Yadav

Punita Yadav currently holds 1 directorship: Payama Pharmaceuticals Private Limited (Director, since 23 Mar 2023, revenue ₹2.8 Lakh (FY 2025)).

Punita Yadav was first appointed on 23 Mar 2023 as Director at Payama Pharmaceuticals Private Limited.

The current boards of Punita Yadav's companies include Raj Kumar Yadav (Payama Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available